Bradford Hill

What Bradford Hill does

Bradford Hill is a Chilean clinical cancer research center that operates two facilities: its headquarters in Santiago (Recoleta) and a satellite site, Bradford Hill Norte (BHN), in Antofagasta. Founded approximately in 2010, the organization has positioned itself as a leader in clinical cancer research in Chile for over 15 years, with a specialization in immunotherapy clinical trials. Its core offering consists of experimental, multicenter oncology trials covering solid tumors including gastric and gastroesophageal junction adenocarcinoma, hormone-sensitive advanced breast cancer, colorectal cancer, and head and neck squamous cell carcinoma. Trials involve established immunotherapies such as nivolumab, atezolizumab, and durvalumab, alongside newer candidates such as MK2870-015 and MK2870-010.

The organization supports trial execution with state-of-the-art clinical infrastructure, a dedicated Ethics Committee that protects participant rights and safety, and a research team led by Executive Director Dr. Carlos Rojas. The business model is structured around clinical trial operations funded by pharmaceutical company sponsorships, research grants, and public health funding, rather than direct patient billing. Trials are voluntary and provided free of charge to eligible patients across Chile who meet defined medical and psychological criteria, with patient recruitment conducted through a website-based evaluation request system, social media, and earned media coverage.

Distribution is entirely domestic within Chile and delivered through the two physical centers, with no international patient operations. Bradford Hill actively participates in international oncology forums, most notably as the only Spanish-speaking entity at ASCO 2025 in Chicago, and disseminates research outputs through its publications portal and partnerships with global pharmaceutical trial sponsors.

Name

Bradford Hill

Legal name

Bradford Hill

Website

https://bradfordhill.org

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Bradford Hill is a Chilean clinical cancer research center operating in Santiago and Antofagasta, specializing in experimental immunotherapy clinical trials for solid tumors. It serves Chilean cancer patients who have failed prior treatments by providing free access to cutting-edge oncology trials sponsored by global pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Clinical Oncology Research

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Liver & GI Clinical Research (Trials Centers) (HLAKAEAL)

akta.pro secondary industries

Hepatology & Liver Disease (HLAKAEAB), Gastrointestinal Oncology (HLAKAFAK)

Keywords

• Clinical cancer research
• Immunotherapy clinical trials
• Oncology research services
• Experimental cancer treatment
• Multicenter clinical trials

Headquarters

HQ city

Recoleta

HQ country

Chile

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Trial Operations: Bradford Hill operates as a non-profit clinical research center providing free treatment to patients who meet criteria for experimental clinical trials. Revenue is generated through research grants, pharmaceutical company sponsorships, and potentially public health funding rather than direct patient billing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Bradford Hill is a clinical cancer research center that recruits eligible Chilean cancer patients into experimental multicenter clinical trials, with a specialization in immunotherapy. Patients meeting medical and psychological criteria receive free integral cancer treatment as part of sponsored trials investigating therapies such as nivolumab, atezolizumab, and durvalumab across solid tumor types including gastric, breast, colorectal, and head and neck cancers.

Product overview

Bradford Hill is a cancer research center operating in Santiago and Antofagasta, Chile, offering a portfolio of clinical research services centered on experimental clinical trials and immunotherapy treatments. The core offering consists of clinical cancer research trials conducted as world-class multicenter scientific investigations focused on immunotherapy. Supporting services include the Ethics Committee for participant protection, Publications for research dissemination, Patient Evaluation Service for trial eligibility assessment, and Bradford Hill Norte (BHN) as a satellite research facility. The company has been a leader in clinical cancer research in Chile for over 15 years.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Cancer Research Trials World-class multicenter scientific investigations that define new therapies and approach protocols, especially in immunotherapy, offered to Chilean cancer patients who meet the required medical and psychological criteria. Conducted at centers in Santiago and Antofagasta.
• Immunotherapy Treatments Experimental cancer treatments utilizing the patient's immune system to recognize and attack cancer cells, incorporating early-stage immunotherapy for solid tumor types including stomach, breast, colorectal, head and neck, and gastric cancers.
• Bradford Hill Norte (BHN) A satellite clinical research facility in Antofagasta that expands Bradford Hill's clinical trial operations, participating in studies such as breast cancer trials alongside the main Santiago center and serving patients from northern Chile.
• Patient Evaluation Service A dedicated intake service that evaluates patients to determine if they meet the required medical and psychological criteria for participation in experimental clinical trials, accessed via the website evaluation request system.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• American Society of Clinical Oncology (ASCO)coreStrategic or Co-development PartnerBradford Hill participated as the only Spanish-speaking entity at ASCO 2025 annual congress held May 30 - June 3 in Chicago. Dr. Carlos Rojas, executive director, attended all five sessions accessing the latest in oncology research, clinical trials, and therapeutic innovations.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Parexel International: Global CRO with significant LATAM oncology trial operations, including site management and patient enrollment. Comparable ecosystem participant to Bradford Hill from the sponsor-services side of the same clinical trial workflow.
• ICON plc: Global CRO with LATAM operations that manages oncology trials and competes for the same sponsor relationships as Bradford Hill. Comparable as an ecosystem participant and potential indirect competitor for trial-site volume.
• START (South Texas Accelerated Research Therapeutics): Global oncology-focused clinical trial site network operating across multiple continents, with extensive experience running Phase I immunotherapy trials. Comparable to Bradford Hill as an oncology-specialized trial site network, but at substantially larger geographic and operational scale.
• IQVIA: World's largest contract research organization managing oncology trials across LATAM, including Chile. While Bradford Hill is a trial site and IQVIA is a sponsor-facing CRO, both operate in the same trial execution ecosystem and address the same multinational sponsors and patients.
• Syneos Health: Global biopharma services organization (CRO) with oncology trial management capabilities and LATAM site network. Operates in the same clinical trial ecosystem and competes for sponsor mindshare that ultimately drives trial volume at sites like Bradford Hill.
• MD Anderson Cancer Center: One of the world's leading academic cancer centers, running a high volume of immunotherapy clinical trials. Comparable as a leading oncology trial site, though at vastly greater scale and as part of a US-based comprehensive cancer center vs. Bradford Hill's Chilean independent model.

Regional players

• A.C.Camargo Cancer Center: Brazil's largest private cancer center, conducting sponsored clinical trials across LATAM. Comparable LATAM cancer trial site, but based in Brazil and serving a different national jurisdiction than Bradford Hill's Chile focus.
• Hospital Israelita Albert Einstein: Brazilian academic medical center with active oncology clinical trial operations and international sponsor partnerships. Comparable as a LATAM cancer trial site, though operating in Brazil rather than Chile.

Direct peers

• Clínica Alemana de Santiago: Major Chilean private hospital and academic medical center with an active oncology department that conducts sponsored clinical trials. Competes with Bradford Hill for Chilean cancer patients and multinational trial enrollment in the same domestic market.
• Fundación Arturo López Pérez (FALP): Chile's leading private cancer institute, providing oncological treatment and running sponsored clinical trials. Directly comparable to Bradford Hill as a domestic Chilean cancer trial site serving the same patient population and competing for the same multinational sponsor trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/BradfordHill.cl
• LinkedInlinkedin.com/company/bradford-hill
• Instagraminstagram.com/bradfordhill.cl

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bradford Hill